Co-localization of Urokinase and its Receptor on Established Human Umbilical Vein Endothelial Cell.
スポンサーリンク
概要
- 論文の詳細を見る
Vascular endothelial cells possess antithrombotic properties, which are determined by the balance between plasminogen activators (PAs) and PA inhibitors (PAIs). A cell line, TKM-33, has been established and cloned from human umbilical vein endothelial cells, was previously reported to produce a large amount of urokinase-type PA (u-PA) and small amounts of tissue-type plasminogen activator (t-PA) and PA inhibitor-1 (PAI-1). Moreover, TKM-33 expressed the u-PA receptor (u-PAR) which plays an important role in the localization of fibrinolytic activity on cell surface. In the present study, we investigated the localization of u-PA, t-PA, PAI-1 and u-PAR in TKM-33 by using immunofluorescence staining technique. The endothelial cells were strongly stained with anti-PAI-1, anti-u-PA and anti-u-PAR IgGs, and slightly with anti-t-PA IgG. The double immunofluorescence staining with mouse anti-u-PA IgG and rabbit anti-u-PAR IgG followed by rhodamine-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit IgG showed the co-localization of u-PA and u-PAR on the same section of endothelial cells. Although u-PA antigen also existed in the cytoplasm of endothelial cells, u-PAR antigen did not. The treatment of endothelial cells with phorbol-myristateacetate (PMA) upregulated the expression of u-PA and u-PAR antigens. In this stimulation, u-PAR antigen was detected not only on the surface of the cells but also in the cytoplasm. Thus, the binding of u-PA to u-PAR was confirmed by double immunofluorescence staining.
- 日本細胞生物学会の論文
日本細胞生物学会 | 論文
- テトラヒメナにおけるDNA-核膜複合体の研究 (細胞核内小器官の生物学)
- 核小体におけるリボゾ-ムRNA合成の制御 (細胞核内小器官の生物学)
- 細胞分裂とその調節-分裂装置をめぐって (細胞増殖と分化)
- 細胞雑種研究の現状 (細胞融合)
- 浮遊増殖性癌細胞の無血清培養と培地添加アルブミンの役割 (細胞融合)